Fernandez-Rachubinski F A, Weiner J H, Blajchman M A
Department of Pathology, McMaster University, Hamilton, Ontario L8N 3Z5, Canada.
J Biol Chem. 1996 Nov 15;271(46):29502-12. doi: 10.1074/jbc.271.46.29502.
We have identified cis-acting elements and trans-acting factors that regulate constitutive expression of the human antithrombin gene. The activity of the sequences flanking the first exon of the gene was investigated using a luciferase-based reporter assay in transiently transfected HepG2, COS1, BSC40, and HeLa cells. Deletion analysis allowed the mapping of two elements able to promote antithrombin gene transcription in HepG2 and COS1 cells. The first element is located upstream of the first exon (-150/+68 nucleotides). The second element is in the first intervening sequence (+300/+700 nucleotides) and functions in an orientation opposite to that of the first. Footprint analysis showed three protected areas in the 5' upstream element at -92/-68 (element A), -14/+37 (element B), and -126/-100 nucleotides (element C). These elements acted as enhancers in luciferase reporter assays. Gel retardation analysis demonstrated that two liver-enriched transcription factors, hepatocyte nuclear factor 4 (HNF4) and CCAAT enhancer-binding protein (C/EBPa), bound to the 5' upstream element. HNF4 bound to elements A and C, whereas C/EBPa bound to element B. Element A also interacted with the ubiquitous nuclear hormone receptors chicken ovalbumin upstream promoter transcription factor 1 (COUP-TF1), thyroid hormone receptor alpha (TRalpha), peroxisome proliferator-activated receptor alpha(PPARalpha), and retinoid X receptor alpha (RXRalpha). In HepG2 and BSC40 cells, HNF4, C/EBPalpha, and RXRalpha activated luciferase expression from a reporter construct containing the 5'-upstream minimal antithrombin gene promoter, while COUP-TF1, TRalpha, and HNF3 (alpha or beta) repressed such expression. Our results show that constitutive expression of the human antithrombin gene depends in part upon the interplay of these transcription factors and suggest that signaling pathways regulated by these factors can modulate antithrombin gene transcription.
我们已经鉴定出调控人抗凝血酶基因组成型表达的顺式作用元件和反式作用因子。使用基于荧光素酶的报告基因检测法,在瞬时转染的HepG2、COS1、BSC40和HeLa细胞中研究了该基因第一个外显子侧翼序列的活性。缺失分析使得能够定位出两个可促进HepG2和COS1细胞中抗凝血酶基因转录的元件。第一个元件位于第一个外显子上游(-150 / +68个核苷酸)。第二个元件位于第一个内含序列中(+300 / +700个核苷酸),其功能方向与第一个元件相反。足迹分析显示在5'上游元件的-92 / -68(元件A)、-14 / +37(元件B)和-126 / -100个核苷酸(元件C)处有三个受保护区域。这些元件在荧光素酶报告基因检测中起增强子的作用。凝胶阻滞分析表明,两种肝脏富集的转录因子,即肝细胞核因子4(HNF4)和CCAAT增强子结合蛋白(C/EBPa),与5'上游元件结合。HNF4与元件A和C结合,而C/EBPa与元件B结合。元件A还与普遍存在的核激素受体鸡卵清蛋白上游启动子转录因子1(COUP-TF1)、甲状腺激素受体α(TRα)、过氧化物酶体增殖物激活受体α(PPARα)和视黄酸X受体α(RXRα)相互作用。在HepG2和BSC40细胞中,HNF4、C/EBPα和RXRα激活了含有5'-上游最小抗凝血酶基因启动子的报告基因构建体的荧光素酶表达,而COUP-TF1、TRα和HNF3(α或β)则抑制了这种表达。我们的结果表明,人抗凝血酶基因的组成型表达部分取决于这些转录因子的相互作用,并表明由这些因子调控的信号通路可以调节抗凝血酶基因的转录。